相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Crosstalk relationship between adiponectin receptors, PPAR-γ and α-adrenoceptors in renal vasculature of diabetic WKYs
Sheryar Afzal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Substance P and Neurokinin 1 Receptor in Chronic Inflammation and Cancer of the Head and Neck: A Review of the Literature
Francisco Esteban et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
The triumvirate of NF-ΚB, inflammation and cytokine storm in COVID-19
Ali Attiq et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
REGULATION AND METABOLIC FUNCTIONS OF mTORC1 AND mTORC2
Angelia Szwed et al.
PHYSIOLOGICAL REVIEWS (2021)
Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats
Sheryar Afzal et al.
PPAR RESEARCH (2021)
A new prenylated benzoquinone from Cyathocalyx pruniferus abrogates LPS-induced inflammatory responses associated with PGE2, COX-2 and cytokines biosynthesis in human plasma
Ali Attiq et al.
INFLAMMOPHARMACOLOGY (2021)
Luteolin and apigenin derived glycosides from Alphonsea elliptica abrogate LPS-induced inflammatory responses in human plasma
Ali Attiq et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Molecular Structure and Function of Janus Kinases: Implications for the Development of Inhibitors
Alba Garrido-Trigo et al.
JOURNAL OF CROHNS & COLITIS (2020)
Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study
Hye Yun Park et al.
THORAX (2020)
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Zhilin Zou et al.
CELL AND BIOSCIENCE (2020)
Modulation of inflammatory pathways, medicinal uses and toxicities ofUvariaspecies: potential role in the prevention and treatment of inflammation
Juriyati Jalil et al.
INFLAMMOPHARMACOLOGY (2020)
NF-κB inhibitors in treatment and prevention of lung cancer
Rajan Radha Rasmi et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Head and neck squamous cell carcinoma
Daniel E. Johnson et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Renoprotective and haemodynamic effects of adiponectin and peroxisome proliferator-activated receptor agonist, pioglitazone, in renal vasculature of diabetic Spontaneously hypertensive rats
Sheryar Afzal et al.
PLOS ONE (2020)
Prostate carcinogenesis: inflammatory storms
Johann S. de Bono et al.
NATURE REVIEWS CANCER (2020)
The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases
Ning Ding et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2019)
Consequences of interleukin 1β-triggered chronic inflammation in the mouse prostate gland: Altered architecture associated with prolonged CD4+ infiltration mimics human proliferative inflammatory atrophy
Arya Ashok et al.
PROSTATE (2019)
Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them
M. A. F. Yahaya et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Dual-Specificity Phosphatases in Immunity and Infection: An Update
Roland Lang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Acylated Ghrelin Renders Chemosensitive Ovarian Cancer Cells Resistant to Cisplatin Chemotherapy via Activation of the PI3K/Akt/mTOR Survival Pathway
Attalla Farag El-kott et al.
ANALYTICAL CELLULAR PATHOLOGY (2019)
PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics
Alia Ghoneum et al.
CANCERS (2019)
Targeting YAP suppresses ovarian cancer progression through regulation of the PI3K/Akt/mTOR pathway
Xiao Wei et al.
ONCOLOGY REPORTS (2019)
Interplay of MKP-1 and Nrf2 drives tumor growth and drug resistance in non-small cell lung cancer
Hongyan Wang et al.
AGING-US (2019)
Cyclooxygenase-2 in cancer: A review
Nasser Hashemi Goradel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The medicinal uses, toxicities and anti-inflammatory activity of Polyalthia species (Annonaceae)
Lui Jin Yao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
Chemokines in homeostasis and diseases
Keqiang Chen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Mast cells as sources of cytokines, chemokines, and growth factors
Kaori Mukai et al.
IMMUNOLOGICAL REVIEWS (2018)
The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168
Xiaoduo Xie et al.
NATURE CELL BIOLOGY (2018)
PKB/Akt-dependent regulation of inflammation in cancer
Fengyuan Tang et al.
SEMINARS IN CANCER BIOLOGY (2018)
Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications
Sujuan Yang et al.
FRONTIERS IN IMMUNOLOGY (2018)
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
Arianna Calcinotto et al.
NATURE (2018)
Raging the War Against Inflammation With Natural Products
Ali Attiq et al.
FRONTIERS IN PHARMACOLOGY (2018)
PI3K/Akt/mTOR signaling pathway participates in Streptococcus uberis-induced inflammation in mammary epithelial cells in concert with the classical TLRs/NF-κB pathway
Bin Li et al.
VETERINARY MICROBIOLOGY (2018)
Role of nonresolving inflammation in hepatocellular carcinoma development and progression
Le-Xing Yu et al.
NPJ PRECISION ONCOLOGY (2018)
Is Pelvic Inflammatory Disease a Risk Factor for Ovarian Cancer?
Christina B. Rasmussen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Inhibition of PI3K/Akt/mTOR signaling in PI3KR2-overexpressing colon cancer stem cells reduces tumor growth due to apoptosis
Sugong Chen et al.
ONCOTARGET (2017)
Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
Eleni Vergadi et al.
JOURNAL OF IMMUNOLOGY (2017)
Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways
Jun Zhang et al.
JOURNAL OF VIROLOGY (2017)
Tumor-related interleukins: old validated targets for new anti-cancer drug development
Sarra Setrerrahmane et al.
MOLECULAR CANCER (2017)
An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis
L. Zhao et al.
ONCOGENE (2017)
Annonaceae: Breaking the Wall of Inflammation
Ali Attiq et al.
FRONTIERS IN PHARMACOLOGY (2017)
EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells
Honami Takada et al.
PLOS ONE (2017)
Progressive induction of hepatocyte progenitor cells in chronically injured liver
Naoki Tanimizu et al.
SCIENTIFIC REPORTS (2017)
Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer
Jonas J. Staudacher et al.
SCIENTIFIC REPORTS (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Inflammation and Colorectal Cancer
Apple G. Long et al.
CURRENT COLORECTAL CANCER REPORTS (2017)
Opportunities and challenges provided by crosstalk between signalling pathways in cancer
A. Prahallad et al.
ONCOGENE (2016)
Chronic NF-κB activation links COPD and lung cancer through generation of an immunosuppressive microenvironment in the lungs
Rinat Zaynagetdinov et al.
ONCOTARGET (2016)
Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner
Sung-Hak Kim et al.
CANCER CELL (2016)
Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage
Andrea Sau et al.
CELL STEM CELL (2016)
JAK-STAT signaling in cancer: From cytokines to non-coding genome
Jan Pencik et al.
CYTOKINE (2016)
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis
Xue Wang et al.
JOURNAL OF HEPATOLOGY (2016)
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein
Greta Forlani et al.
JOURNAL OF VIROLOGY (2016)
Reparative inflammation takes charge of tissue regeneration
Michael Karin et al.
NATURE (2016)
The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations
Jessica L. Geiger et al.
ORAL ONCOLOGY (2016)
PI3K signalling in inflammation
P. T. Hawkins et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
S. J. Thomas et al.
BRITISH JOURNAL OF CANCER (2015)
Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity
Bing Liu et al.
CANCER CELL INTERNATIONAL (2015)
Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape
Ammad Ahmad Farooqi et al.
CELL BIOCHEMISTRY AND FUNCTION (2015)
Chemosensitization by diverging modulation by short-term and long-term TNF-α action on ABCB1 expression and NF-κB signaling in colon cancer
Wolfgang Walther et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study
Kathleen C. Torkko et al.
JOURNAL OF UROLOGY (2015)
The relationship between COPD and lung cancer
A. L. Durham et al.
LUNG CANCER (2015)
Pelvic Inflammatory Disease
Robert C. Brunham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Macrophages and cancer: from mechanisms to therapeutic implications
Renato Ostuni et al.
TRENDS IN IMMUNOLOGY (2015)
Expression of COX-2 and HER-2 in colorectal cancer and their correlation
Qi-Bing Wu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The role of JAK-STAT signaling in adipose tissue function
Allison J. Richard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
Shanshan Wan et al.
GASTROENTEROLOGY (2014)
Reading between the lines; understanding drug response in the post genomic era
Constantine C. Alifrangis et al.
MOLECULAR ONCOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Laura Bonapace et al.
NATURE (2014)
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
Ramona Rudalska et al.
NATURE MEDICINE (2014)
Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor
Andrew J. Brooks et al.
SCIENCE (2014)
Macrophage cytokines: involvement in immunity and infectious diseases
Guillermo Arango Duque et al.
FRONTIERS IN IMMUNOLOGY (2014)
Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors
Christina B. Rasmussen et al.
CANCER CAUSES & CONTROL (2013)
Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis
William K. K. Wu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Notch1-dependent regulation of p27 determines cell fate in colorectal cancer
Nevyana R. Hristova et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Inflammation and prostate carcinogenesis
Yasutomo Nakai et al.
INTERNATIONAL JOURNAL OF UROLOGY (2013)
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Akintunde Akinleye et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKb
S. Jin et al.
ONCOGENE (2013)
A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes
Debika Biswal Shinohara et al.
PROSTATE (2013)
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Yihui Fan et al.
PROTEIN & CELL (2013)
The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and Microenvironment
Takamitsu Sasaki et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Epidermal Growth Factor and Epidermal Growth Factor Receptor: The Yin and Yang in the Treatment of Cutaneous Wounds and Cancer
Richard J. Bodnar
ADVANCES IN WOUND CARE (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
Anurag Singh et al.
CELL (2012)
Developmental pathways in colon cancer Crosstalk between WNT, BMP, Hedgehog and Notch
Fred E. Bertrand et al.
CELL CYCLE (2012)
Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice
Chao Wang et al.
HEPATOLOGY (2012)
Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease
Lyn M. Wancket et al.
LIFE SCIENCES (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model
Yifeng Xia et al.
NATURE CELL BIOLOGY (2012)
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02
Eudocia Q. Lee et al.
NEURO-ONCOLOGY (2012)
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
Ryan B. Corcoran et al.
CANCER DISCOVERY (2012)
Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation
Giuseppe Vassalli et al.
JOURNAL OF TRANSPLANTATION (2012)
Prostaglandin E2 EP receptors as therapeutic targets in breast cancer
Jocelyn Reader et al.
CANCER AND METASTASIS REVIEWS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Prostaglandin E2 2 Signaling and Bacterial Infection Recruit Tumor-Promoting Macrophages to Mouse Gastric Tumors
Hiroko Oshima et al.
GASTROENTEROLOGY (2011)
Intestinal Inflammation and Cancer
Thomas A. Ullman et al.
GASTROENTEROLOGY (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
The Epithelial Cell and Lung Cancer: The Link between Chronic Obstructive Pulmonary Disease and Lung Cancer
Claire Rooney et al.
RESPIRATION (2011)
Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights
Ian M. Adcock et al.
RESPIRATION (2011)
Roles of Peroxisome Proliferator-Activated Receptor-α and -γ in the Development of Non-Small Cell Lung Cancer
Ming-Yue Li et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Mechanisms and functions of p38 MAPK signalling
Ana Cuadrado et al.
BIOCHEMICAL JOURNAL (2010)
PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling
Ludovic Martinet et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Pathological roles of MAPK signaling pathways in human diseases
Eun Kyung Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation
Guobin He et al.
CANCER CELL (2010)
Requirement of the NF-κB Subunit p65/RelA for K-Ras-Induced Lung Tumorigenesis
Daniela S. Basseres et al.
CANCER RESEARCH (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches
Stephen Y. Lai et al.
DRUG RESISTANCE UPDATES (2010)
Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells
Wei-Lun Huang et al.
MOLECULAR CANCER (2010)
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
Michael C. Haffner et al.
NATURE GENETICS (2010)
Synthetic lethal approaches to breast cancer therapy
Farah L. Rehman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements
Shivanni Kummar et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
MAPK signaling in inflammation-associated cancer development
Pengyu Huang et al.
PROTEIN & CELL (2010)
Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease
Maria G. Belvisi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion
Yadi Wu et al.
CANCER CELL (2009)
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Heehyoung Lee et al.
CANCER CELL (2009)
Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer
Chunru Lin et al.
CELL (2009)
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
Ji Luo et al.
CELL (2009)
NF-kappa B Signaling Pathway, Inflammation and Colorectal Cancer
Soly Wang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Akt-dependent and -independent mechanisms of mTOR regulation in cancer
Regan M. Memmott et al.
CELLULAR SIGNALLING (2009)
NUCLEAR FACTOR KAPPA B INDUCTION IN AIRWAY EPITHELIUM INCREASES LUNG INFLAMMATION IN ALLERGEN-CHALLENGED MICE
James R. Sheller et al.
EXPERIMENTAL LUNG RESEARCH (2009)
Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9
Jing-song Chen et al.
HEPATOLOGY RESEARCH (2009)
Phosphoinositide (3,4,5)-Triphosphate Binding to Phosphoinositide-Dependent Kinase 1 Regulates a Protein Kinase B/Akt Signaling Threshold That Dictates T-Cell Migration, Not Proliferation
Caryll Waugh et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
NF-κB as a Critical Link Between Inflammation and Cancer
Michael Karin
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1
Arnd Kieser
BIOLOGICAL CHEMISTRY (2008)
Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis
Toshiharu Sakurai et al.
CANCER CELL (2008)
Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1
Mark C. Markowski et al.
CANCER RESEARCH (2008)
Improving outcomes in patients with advanced renal cell carcinoma
Jeffrey A. Sosman
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity
Nilofer S. Azad et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
Alan Ashworth
JOURNAL OF CLINICAL ONCOLOGY (2008)
Basic and clinical aspects of non-neuronal acetylcholine: Expression of non-neuronal acetylcholine in urothelium and its clinical significance
Masaki Yoshida et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Origin and physiological roles of inflammation
Ruslan Medzhitov
NATURE (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Mitogen-activated protein (MAP) Kinase/MAP kinase phosphatase regulation: Roles in cell growth, death, and cancer
Tarek Boutros et al.
PHARMACOLOGICAL REVIEWS (2008)
Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer
Gen Sheng Wu
CANCER AND METASTASIS REVIEWS (2007)
Inflammation, atrophy, and prostate carcinogenesis
Angelo M. De Marzo et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2007)
Nicotine induces hypoxia-inducible factor-1α expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways
Qunzhou Zhang et al.
CLINICAL CANCER RESEARCH (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Vascular endothelial growth factor and its relationship to inflammatory mediators
Laura S. Angelo et al.
CLINICAL CANCER RESEARCH (2007)
Genetic deletion of PKR abrogates TNF-induced activation of IκBα kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation
Y. Takada et al.
ONCOGENE (2007)
Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells
Diane L. Carlisle et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis
Sachie Hiratsuka et al.
NATURE CELL BIOLOGY (2006)
Molecular cross-talk between the NFκB and STAT3 signaling pathways in head and neck squamous cell carcinoma
Cristiane H. Squarize et al.
NEOPLASIA (2006)
Strategies for optimizing combinations of molecularly targeted anticancer agents
Janet E. Dancey et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
IL-23 promotes tumour incidence and growth
John L. Langowski et al.
NATURE (2006)
Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation
Toshiharu Sakurai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Interleukin-6 and chronic inflammation
Cem Gabay
ARTHRITIS RESEARCH & THERAPY (2006)
Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
J Condeelis et al.
CELL (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
MAPK signalling pathways as molecular targets for anti-inflammatory therapy - from molecular mechanisms to therapeutic benefits
B Kaminska
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Suppression of metastatic colonization by the context-dependent activation of the c-jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7
DJV Griend et al.
CANCER RESEARCH (2005)
AKT crystal structure and AKT-specific inhibitors
CC Kumar et al.
ONCOGENE (2005)
Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck
P Amornphimoltham et al.
CANCER RESEARCH (2005)
Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma
Y Niwa et al.
ONCOGENE (2005)
Role of metabolism and viruses in aflatoxin-induced liver cancer
JD Groopman et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis
X Ouyang et al.
CANCER RESEARCH (2005)
Prostate carcinogenesis and inflammation: emerging insights
GS Palapattu et al.
CARCINOGENESIS (2005)
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
S Maeda et al.
CELL (2005)
IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma
I Garcia-Tuñón et al.
HISTOPATHOLOGY (2005)
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
F Balkwill et al.
CANCER CELL (2005)
A subtle change in p38 MAPK activity is sufficient to suppress in vivo tumorigenesis
O Timofeev et al.
CELL CYCLE (2005)
Regulation of anoikis by Cdc42 and Rac1
TL Cheng et al.
EXPERIMENTAL CELL RESEARCH (2004)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation
M Luftig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ2 in oral squamous carcinoma cells
H Siavash et al.
BRITISH JOURNAL OF CANCER (2004)
IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
FR Greten et al.
CELL (2004)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Prostanoids and their receptors that modulate dendritic cell-mediated immunity
N Gualde et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01
P Amornphimoltham et al.
CLINICAL CANCER RESEARCH (2004)
Chemokines: role in inflammation and immune surveillance
B Moser et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Mechanism of p38 MAP kinase activation in vivo
D Brancho et al.
GENES & DEVELOPMENT (2003)
Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes
H Harizi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases
H Fujino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Jiyong Liang et al.
CELL CYCLE (2003)
The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia
A Ferrajoli et al.
BLOOD (2002)
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity
DV Bulavin et al.
NATURE GENETICS (2002)
Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2
H Fujino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT1A cells
L Guillemot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer
XF Chen et al.
ONCOGENE (2001)
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
M Sonoshita et al.
NATURE MEDICINE (2001)
Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis
SY Huang et al.
ONCOGENE (2001)
Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38
LV Madrid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Prostaglandin E2 increases growth and motility of colorectal carcinoma cells
HM Sheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
H Yoshikawa et al.
NATURE GENETICS (2001)
Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFκB activation without interfering with the IκB degradation pathway
D Koul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transforming growth factor-beta 1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism
NA Bhowmick et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis
LM Coussens et al.
CELL (2000)
Viruses, immunity, and cancer: Lessons from hepatitis B
FV Chisari
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
